| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 20th January 2021 | David J Matlin | 2,426 | Grant/award etc. | $0.00 | |
| 29th December 2020 | Wtt Med Avail Ltd Abg | 45 | Open or private purchase | $14.00 | $630.00 |
| 29th December 2020 | Wtt Med Avail Ltd Abg | 55 | Open or private purchase | $14.00 | $770.00 |
| 28th December 2020 | Wtt Med Avail Ltd Abg | 3,894 | Open or private purchase | $13.98 | $54,424.88 |
| 28th December 2020 | Wtt Med Avail Ltd Abg | 3,213 | Open or private purchase | $13.98 | $44,906.82 |
| 17th December 2020 | Wtt Med Avail Ltd Abg | 6,946 | Open or private purchase | $13.12 | $91,132.21 |
| 17th December 2020 | Wtt Med Avail Ltd Abg | 5,731 | Open or private purchase | $13.12 | $75,191.29 |
| 17th December 2020 | Wtt Med Avail Ltd Abg | 1,248 | Open or private purchase | $14.00 | $17,472.00 |
| 17th December 2020 | Wtt Med Avail Ltd Abg | 1,029 | Open or private purchase | $14.00 | $14,406.00 |
| 16th December 2020 | Wtt Med Avail Ltd Abg | 12,851 | Open or private purchase | $13.06 | $167,848.20 |
Myos Rens Technology
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
MYOS RENS Technology, Inc. engages in the discovery, development, and commercialization of advanced nutrition products, functional foods, and other technologies. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk.
Ticker: MYOS
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1402479
Employees: 15
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.